Generalizability of clinical trials for cannabis dependence to community samples

Drug and Alcohol Dependence

Volumn 111, Issue 1-2, 2010, Pages 177-181

  Okuda, Mayumi ^a   Hasin, Deborah S ^a,b   Olfson, Mark ^a   Khan, Sharaf S ^a   Nunes, Edward V ^a   Montoya, Ivan ^c   Liu, Shang Min ^a   Grant, Bridget F ^d   Blanco, Carlos ^a  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^b Columbia University ^*  (United States)

^c NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^d NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

Author keywords

Cannabis dependence; Clinical trials; Eligibility criteria; Epidemiology; Exclusion criteria; Generalizability; Inclusion criteria

Indexed keywords

ALCOHOLISM; ARTICLE; CANNABIS ADDICTION; CLINICAL RESEARCH; COMMUNITY LIVING; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG ABUSE; DRUG DEPENDENCE; HUMAN; PREVALENCE; PRIORITY JOURNAL; PSYCHOSIS; SUICIDAL IDEATION;

ADOLESCENT; ADULT; CLINICAL TRIALS AS TOPIC; FEMALE; HUMANS; MALE; MARIJUANA ABUSE; MARIJUANA SMOKING; PATIENT SELECTION;

CANNABIS;

EID: 77956191822     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2010.04.009     Document Type: Article

References (62)

1. Agosti V., Nunes E., Levin F. Rates of psychiatric comorbidity among US residents with lifetime cannabis dependence. Am. J. Drug Alcohol Abuse 2002, 28:643-652.
2. Australian Institute of Health and Welfare, 2009. Alcohol and other drug treatment services in Australia 2007-2008: report on the national minimum data set. Drug Treatment Series no. 9 Cat no. HSE 73, Canberra, Australia.
3. Babor T.F., Longabaugh R., Zweben A., Fuller R.K., Stout R.L., Anton R.F., Randall C.L. Issues in the definition and measurement of drinking outcomes in alcoholism treatment research. J. Stud. Alcohol 1994, 12:101-111.
4. Blanco C., Olfson M., Goodwin R.D., Ogburn E., Liebowitz M.R., Nunes E.V., Hasin D.S. Generalizability of clinical trial results for major depression to community samples: results from the National epidemiologic survey on alcohol and related conditions. J. Clin. Psychiat. 2008, 69:1276-1280.
5. Blanco C., Olfson M., Okuda M., Nunes E.V., Liu S.M., Hasin D.S. Generalizability of clinical trials for alcohol dependence to community samples. Drug Alcohol Depend. 2008, 98:123-128.
6. Bonsack C., Montagrin Y., Favrod J., Gibellini S., Conus P. Motivational interviewing for cannabis users with psychotic disorders. Encephale 2007, 33:819-826.
7. Braslow J.T., Duan N., Starks S.L., Polo A., Bromley E., Wells K.B. Generalizability of studies on mental health treatment and outcomes, 1981 to 1996. Psychiatr. Serv. 2005, 56:1261-1268.
8. Brooner R.K., King V.L., Kidorf M., Schmidt C.W., Bigelow G.E. Psychiatric and substance use comorbidity among treatment-seeking opioid abusers. Arch. Gen. Psychiatry 1997, 54:71-80.
9. Canino G., Bravo M., Ramirez R., Febo V.E., Rubio-Stipec M., Fernandez R.L., Hasin D. The spanish alcohol use disorder and associated disabilities interview schedule (AUDADIS): reliability and concordance with clinical diagnoses in a Hispanic population. J. Stud. Alcohol 1999, 60:790-799.
10. Carroll K.M. Methodological issues and problems in assessment of substance use. Psychol. Assess. 1995, 7:349-358.
11. Carroll K.M., Nich C., McLellan A.T., McKay J.R., Rounsaville B.J. " Research" versus " real-world" patients: representativeness of participants in clinical trials of treatment for cocaine dependence. Drug Alcohol Depend. 1999, 54:171-177.
12. Chatterji S., Saunders J.B., Vrasti R., Grant B.F., Hasin D., Mager D. Reliability of the alcohol and drug modules of the alcohol use disorder and associated disabilities interview schedule-alcohol/drug-revised (AUDADIS-ADR): an international comparison. Drug Alcohol Depend. 1997, 47:171-185.
13. Cohen P., Cohen J. The Clinician's illusion. Arch. Gen. Psychiatry 1984, 41:1178-1182.
14. Compton W.M., Cottler L.B., Jacobs J.L., Ben-Abdallah A., Spitznagel E.L. The role of psychiatric disorders in predicting drug dependence treatment outcomes. Am. J. Psychiatry 2003, 160:890-895.
15. Compton W.M., Grant B.F., Colliver J.D., Glantz M.D., Stinson F.S. Prevalence of marijuana use disorders in the United States: 1991-1992 and 2001-2002. JAMA 2004, 291:2114-2121.
16. Copeland J., Swift W. Cannabis use disorder: epidemiology and management. Int. Rev. Psychiatry 2009, 21:96-103.
17. Copeland J., Swift W., Rees V. Clinical profile of participants in a brief intervention program for cannabis use disorder. J. Subst. Abuse Treat. 2001, 20:45-52.
18. Cottler L.B., Grant B.F., Blaine J., Mavreas V., Pull C., Hasin D., Compton W.M., Rubio-Stipec M., Mager D. Concordance of DSM-IV alcohol and drug use disorder criteria and diagnoses as measured by AUDADIS-ADR, CIDI and SCAN. Drug Alcohol Depend. 1997, 47:195-205.
19. Denis C., Lavie E., Fatséas M., Auriacombe M. Psychotherapeutic interventions for cannabis abuse and/or dependence in outpatient settings. Cochrane Database Syst. Rev. 2006, 3:CD005336.
20. Dennis M., Godley S.H., Diamond G., Tims F.M., Babor T., Donaldson J., Liddle H., Titus J.C., Kaminer Y., Webb C., Hamilton N., Funk R. The Cannabis Youth Treatment (CYT) Study: main findings from two randomized trials. J. Subst. Abuse Treat. 2004, 27:197-213.
21. Edwards J., Elkins K., Hinton M., Harrigan S.M., Donovan K., Athanasopoulos O., McGorry P.D. Randomized controlled trial of a cannabis-focused Intervention for young people with first-episode psychosis. Acta Psychiatr. Scand. 2006, 114:109-117.
22. European Monitoring Centre for Drugs and Drug Addiction, 2004. Cannabis problems in context: understanding the increase in European treatment demands. EMCDDA 2004 Annual report on the state of the drugs problem in the European Union and Norway, Lisbon, Portugal.
23. Findling R.L., Pagano M.E., McNamara N.K., Stansbrey R.J., Faber J.E., Lingler J., Demeter C.A., Bedoya D., Reed M.D. The short-term safety and efficacy of fluoxetine in depressed adolescents with alcohol and cannabis use disorders: a pilot randomized placebo-controlled trial. Child Adolesc. Psychiatry Ment. Health 2009, 3:11.
24. Grant, B., Moore, T.C., Shepard, J., Kaplan, K., 2003a. Source and Accuracy Statement: Wave 1 National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). (accessed on 5.09.2008). http://www.niaaa.nih.gov/.
25. Grant B.F. Comorbidity between DSM-IV drug use disorders and major depression: results of a national survey of adults. J. Subst. Abuse. 1995, 7:481-497.
26. Grant B.F., Dawson D.A., Stinson F.S., Chou P.S., Kay W., Pickering R. The alcohol use disorder and associated disabilities interview schedule-IV (AUDADIS-IV): reliability of alcohol consumption, tobacco use, family history of depression and psychiatric diagnostic modules in a general population sample. Drug Alcohol Depend. 2003, 71:7-16.
27. Grant, B.F., Hasin, D.S., 2001. The Alcohol use Disorder and Associated Disabilities Interview Schedule-DSM-IV Version. (accessed on 5.09.2008). http://www.niaaa.nih.gov/.
28. Grant B.F., Pickering R. The relationship between cannabis use and DSM-IV cannabis abuse and dependence: results from the National longitudinal alcohol epidemiologic survey. J. Subst. Abuse 1998, 10:255-264.
29. Grant B.F., Stinson F.S., Dawson D.A., Chou S.P., Dufour M.C., Compton W., Pickering R.P., Kaplan K. Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch. Gen. Psychiatry 2004, 61:807-816.
30. Grant B.F., Stinson F.S., Dawson D.A., Chou S.P., Ruan W.J., Pickering R.P. Co-occurrence of 12-month alcohol and drug use disorders and personality disorders in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch. Gen. Psychiatry 2004, 61:361-368.
31. Hasin D., Carpenter K.M., McCloud S., Smith M., Grant B.F. The alcohol use disorder and associated disabilities interview schedule (AUDADIS): reliability of alcohol and drug modules in a clinical sample. Drug Alcohol Depend. 1997, 44:133-141.
32. Humphreys K., Weingardt K.R., Harris A.H.S. Influence of subject eligibility criteria on compliance with national institutes of health guidelines for inclusion of women, minorities, and children in treatment research. Alcohol Clin. Exp. Res. 2007, 31:988-995.
33. Humphreys K., Weingardt K.R., Horst D., Joshi A.A., Finney J.W. Prevalence and predictors of research participant eligibility criteria in alcohol treatment outcome studies, 1970-1998. Addiction 2005, 100:1249-1257.
34. Humphreys K., Weisner C. Use of exclusion criteria in selected research subjects and its effect on the generalizability of alcohol treatment outcome studies. Am. J. Psychiatry 2000, 157:588-594.
35. Institute of Medicine Bridging the Gap between Practice and Research 1998, National Academy Press, Washington DC.
36. Kay-Lambkin F.J., Baker A.L., Lewin T.J., Carr V.J. Computer-based psychological treatment for comorbid depression and problematic alcohol and/or cannabis use: a randomized controlled trial of clinical efficacy. Addiction 2009, 104:378-388.
37. Kirchner J.E., Booth B.M., Owen R.R., Lancaster A.E., Smith G.R. Predictors of patient entry into alcohol treatment after initial diagnosis. J. Behav. Health. Serv. Res. 2000, 27:339-346.
38. Martin G., Copeland J. The adolescent cannabis check-up: randomized trial of a brief intervention for young cannabis users. J. Subst. Abuse Treat. 2008, 34:407-414.
39. McCambridge J., Slym R.L., Strang J. Randomized controlled trial of motivational interviewing compared with drug information and advice for early intervention among young cannabis users. Addiction 2008, 103:1809-1818.
40. McKay J.R., Alterman A.I., Koppenhaver J.M., Mulvaney F.D., Bovasso G.B., Ward K. Continuous, categorical, and time to event cocaine use outcome variables: degree of intercorrelation and sensitivity to treatment group differences. Drug Alcohol Depend. 2001, 62:19-30.
41. McLellan A.T., Luborsky L., Woody G.E., O'Brien C.P., Druley K.A. Predicting response to alcohol and drug abuse treatments: role of psychiatric severity. Arch. Gen. Psychiatry 1983, 40:620-625.
42. McRae A.L., Budney A.J., Brady K.T. Treatment of marijuana dependence: a review of the literature. J. Subst. Abuse Treat. 2003, 24:369-376.
43. McRae A.L., Hedden S.L., Malcolm R.J., Carter R.E., Brady K.T. Characteristics of cocaine- and marijuana-dependent subjects presenting for medication treatment trials. Addict. Behav. 2007, 32:1433-1440.
44. National Institute on Drug Abuse, 2009a. American Recovery and Reinvestment Act of 2009 (Recovery Act): 07-DA-102 Development of methodologies and scientific tools for improving and/or assessing the external validity of randomized clinical trial (RCT) results to known populations. (accessed on 10.08.2009). http://www.drugabuse.gov/Recovery/NIDAChallenge.html.
45. National Institute on Drug Abuse, 2009b. The National Drug Abuse Treatment Clinical Trials Network (U10) (accessed on 26.08.2009). http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-10-009.html.
46. National Institute on Drug Abuse, 2009c. National Drug Abuse Treatment: Clinical Trials Network. (Accessed on 24.08.2009). http://www.drugabuse.gov/CTN/home.html.
47. Posternak M., Zimmerman M., Keitner G.I., Miller I.W. A reevaluation of the exclusion criteria used in antidepressant efficacy trials. Am. J. Psychiatry 2002, 159:191-200.
48. Project MATCH Research Group Matching alcoholism treatments to client heterogeneity: project MATCH posttreatment drinking outcomes. J. Stud. Alcohol. 1997, 58:7-29.
49. Rathbone J., Variend H., Mehta H. Cannabis and schizophrenia. Cochrane Database Syst. Rev. 2008, 3:CD004837.
50. Software for Survey Data Analysis (SUDAAN), Version 9.0 2004, Research Triangle Institute, Research Triangle Institute Research Triangle Park, NC.
51. Spall H.G.V., Toren A., Kiss A., Fowler R.A. Eligibility criteria of randomized controlled trials published in high-impact general medical journals: a systematic sampling review. JAMA 2007, 297:1233-1240.
52. Stephens R.S., Babor T.F., Kadden R., Miller M. The Marijuana Treatment Project: rationale, design and participant characteristics. Addiction 2002, 97:109-124. Marijuana Treatment Project Research Group.
53. Stinson F.S., Grant B.F., Dawson D.A., Ruan W.J., Huang B., Saha T. Comorbidity between DSM-IV alcohol and specific drug use disorders in the United States: results from the National epidemiologic survey on alcohol and related conditions. Drug Alcohol Depend. 2005, 80:105-116.
54. Substance Abuse and Mental Health Services Administration Office of Applied Studies, 2009. The TEDS Report: substance abuse treatment admissions referred by the criminal justice system. Rockville, MD.
55. The Marijuana Treatment Project Research Group Brief treatments for cannabis dependence: findings from a randomized multisite trial. J. Consult. Clin. Psychol. 2004, 72:455-466.
56. United Nations Office on Drugs and Crime, 2006. Bulletin on narcotics: Review of the world cannabis situation. Available at (accessed on 9.02.2010). http://www.unodc.org/unodc/en/bulletin_on_narcotics.html.
57. Ustün B., Compton W., Mager D., Babor T., Baiyewu O., Chatterji S., Cottler L., Göĝüş A., Mavreas V., Peters L., Pull C., Saunders J., Smeets R., Stipec M.R., Vrasti R., Hasin D., Room R., Brink W.V.d., Regier D., Blaine J., Grant B.F., Sartorius N. WHO study on the reliability and validity of the alcohol and drug use disorder instruments: overview of methods and results. Drug Alcohol Depend. 1997, 47:161-169.
58. Velasquez M.M., DiClemente C.C., Addy R.C. Generalizability of project MATCH: a comparison of clients enrolled to those not enrolled in the study at one aftercare site. Drug Alcohol Depend. 2000, 59:177-182.
59. Weisner C., Matzger H. A prospective study of the factors influencing entry to alcohol and drug treatment. J. Behav. Health Serv. Res. 2002, 29:126-137.
60. Wisniewski S.R., Rush A.J., Nierenberg A.A., Gaynes B.N., Warden D., Luther J.F., McGrath P.J., Lavori P.W., Thase M.E., Fava M., Trivedi M.H. Can phase III trial results of antidepressant medications be generalized to clinical practice? A STAR*D report. Am. J. Psychiatry 2009, 166:599-607.
61. Wu L.T., Ringwalt C.L. Alcohol dependence and use of treatment services among women in the community. Am. J. Psychiatry 2004, 161:1790-1797.
62. Zimmerman M., Chelminski I., Posternak M.A. Exclusion criteria used in antidepressant efficacy trials: consistency across studies and representativeness of samples included. J. Nerv. Ment. Dis. 2004, 192:87-94.